Cargando…
The use of Janus kinase inhibitors in the time of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
by the American Academy of Dermatology, Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144601/ https://www.ncbi.nlm.nih.gov/pubmed/32278797 http://dx.doi.org/10.1016/j.jaad.2020.03.099 |
| _version_ | 1783519866542620672 |
|---|---|
| author | Peterson, Danielle Damsky, William King, Brett |
| author_facet | Peterson, Danielle Damsky, William King, Brett |
| author_sort | Peterson, Danielle |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7144601 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | by the American Academy of Dermatology, Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71446012020-04-09 The use of Janus kinase inhibitors in the time of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Peterson, Danielle Damsky, William King, Brett J Am Acad Dermatol JAAD Online by the American Academy of Dermatology, Inc. 2020-06 2020-04-09 /pmc/articles/PMC7144601/ /pubmed/32278797 http://dx.doi.org/10.1016/j.jaad.2020.03.099 Text en © 2020 by the American Academy of Dermatology, Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | JAAD Online Peterson, Danielle Damsky, William King, Brett The use of Janus kinase inhibitors in the time of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
| title | The use of Janus kinase inhibitors in the time of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
| title_full | The use of Janus kinase inhibitors in the time of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
| title_fullStr | The use of Janus kinase inhibitors in the time of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
| title_full_unstemmed | The use of Janus kinase inhibitors in the time of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
| title_short | The use of Janus kinase inhibitors in the time of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
| title_sort | use of janus kinase inhibitors in the time of severe acute respiratory syndrome coronavirus 2 (sars-cov-2) |
| topic | JAAD Online |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144601/ https://www.ncbi.nlm.nih.gov/pubmed/32278797 http://dx.doi.org/10.1016/j.jaad.2020.03.099 |
| work_keys_str_mv | AT petersondanielle theuseofjanuskinaseinhibitorsinthetimeofsevereacuterespiratorysyndromecoronavirus2sarscov2 AT damskywilliam theuseofjanuskinaseinhibitorsinthetimeofsevereacuterespiratorysyndromecoronavirus2sarscov2 AT kingbrett theuseofjanuskinaseinhibitorsinthetimeofsevereacuterespiratorysyndromecoronavirus2sarscov2 AT petersondanielle useofjanuskinaseinhibitorsinthetimeofsevereacuterespiratorysyndromecoronavirus2sarscov2 AT damskywilliam useofjanuskinaseinhibitorsinthetimeofsevereacuterespiratorysyndromecoronavirus2sarscov2 AT kingbrett useofjanuskinaseinhibitorsinthetimeofsevereacuterespiratorysyndromecoronavirus2sarscov2 |